medigraphic.com
Colegio de Medicina Interna de México.

2021, Número 3

<< Anterior Siguiente >>

Med Int Mex 2021; 37 (3)


COVID-19, enfermedad de Kawasaki y síndromes inflamatorios multisistémicos: una conceptualización desde los principales reportes

Polo-Martínez M, Montiel-Mejía J, Batista-Castellar V, Contreras-Puentes N, Conde-Cardona GC

Idioma: Español
Referencias bibliográficas: 52
Paginas: 373-382
Archivo PDF: 229.94 Kb.


RESUMEN

Objetivo: Describir las características clínicas de pacientes con COVID-19 y una variedad atípica de la enfermedad de Kawasaki con procesos inflamatorios sistémicos en niños y sus procedimientos diagnósticos y terapéuticos.
Metodología: Revisión bibliográfica narrativa, a partir de la consulta en las bases de datos de: PubMed, Science Direct y Google académico. Para la búsqueda se utilizaron las palabras clave (MeSH): “COVID-19”, “Kawasaki Disease”, “SARS-CoV-2”, “multisystem inflammatory syndrome”. Se incluyeron artículos originales y reportes de casos clínicos.
Resultados: Se encontraron 52 artículos, de ellos se seleccionaron 27 que reunieron los criterios de inclusión para su análisis.
Conclusiones: Con las manifestaciones clínicas asociadas con la COVID-19 aparecieron cuadros inflamatorios multisistémicos atípicos y la enfermedad de Kawasaki establece una urgencia de datos precisos y prospectivos de este síndrome que logre diferenciar, en su totalidad, la de Kawasaki o, en su defecto, definirla como una variante de la misma. Los médicos a cargo de pacientes con COVID-19 deben conocer los criterios diagnósticos del nuevo síndrome y estar alertas, sobre todo en países con número de casos constantes donde podría verse la mayoría de pacientes complicados luego de la infección por SARS-CoV-2. Además, estas actualizaciones de la investigación implican una perspectiva aún más profunda para el estudio fisiopatológico, la indicación del tratamiento y la conceptualización de las bases clínicas para su entendimiento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. WHO. Coronavirus disease (COVID-19) Situation Report -188. 2020; 1-16. https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/situation-reports.

  2. Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506. https://doi. org/10.1016/S0140-6736(20)30183-5.

  3. Guan WJ, Liang WH, Zhao Y, Liang HR, et al. Comorbidity and its impact on 1,590 patients with Covid-19 in China: A nationwide analysis. Eur Respir J 2020; 55 (5): 2000547. doi. 10.1183/13993003.00547-2020.

  4. Jones VG, Mills M, Suarez D, Hogan CA, et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr 2020; 10 (6): 537-40. https://doi.org/10.1542/ hpeds.2020-0123.

  5. Prego-Petit J. Enfermedad de Kawasaki. Arch Pediatr 2006; 7 (2): 70-83.

  6. Soni PR, Noval Rivas M, Arditi M. A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis. Curr Rheumatol Rep 2020; 22 (2). https://doi.org/10.1007/ s11926-020-0882-1.

  7. Freeman AF, Shulman ST. Kawasaki disease: Summary of the American Heart Association guidelines. Am Fam Physician 2006; 74 (7): 1141-50. https://www.aafp.org/ afpsort.xml.

  8. Verdoni L, Mazza A, Gervasoni A, Martelli L, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395 (10239): 1771-8. http://dx.doi. org/10.1016/S0140-6736(20)31103-X.

  9. Holman RC, Belay ED, Christensen KY, Folkema AM, et al. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 2010; 29 (6): 483-8. doi. 10.1097/INF.0b013e3181cf8705.

  10. McCrindle BW, Rowley AH, Newburger JW, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017; 135: 927-99. https://doi.org/10.1161/ CIR.0000000000000484.

  11. Cogan E, Foulon P, Cappeliez O, Dolle N, et al. Multisystem inflammatory syndrome with complete Kawasaki disease features associated with SARS-CoV-2 infection in a young. Frontiers in Medicine 2020; 428. https://doi.org/10.3389/ fmed.2020.00428.

  12. Ouldali N, Pouletty M, Mariani P, Beyler C, et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Heal 2020; 4 (9): 662-8. http://dx.doi.org/10.1016/S2352-4642(20)30175-9.

  13. Belot A, Antona D, Renolleau S, Javouhey E, et al. SARS-CoV- 2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill 2020; 25 (22): 2001010.

  14. Belhadjer Z, Méot M, Bajolle F, Khraiche D, et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation 2020; 429-36. https://doi.org/10.1161/ CIRCULATIONAHA.120.048360.

  15. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395 (10237): 1607-8. http://dx.doi. org/10.1016/S0140-6736(20)31094-1.

  16. Davies P, Evans C, Kanthimathinathan HK, Lillie J, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet 2020; 4(20): 669-77. https:// doi.org/10.1016/S2352-4642(20)30215-7.

  17. Toubiana J. Outbreak of Kawasaki disease in children during COVID-19 pandemic a prospective observational study in Paris France. BMJ 2020;369:m2094. http://medrxiv.org/ cgi/content/short/2020.05.10.20097394.

  18. Ulloa-Gutiérrez R, Ivankovich-Escoto G, Yamazaki- Nakashimada MA. Síndrome inflamatorio multisistémico asociado a COVID-19 en niños y adolescentes: un llamado al diagnóstico. Rev Chil Infectología 2020; 37 (3): 199-201. http://dx.doi.org/10.4067/s0716-10182020000300199.

  19. Loomba RS, Villarreal E, Flores S. Reply to the letter concerning Kawasaki Disease and Covid-19. Cardiol Young 2020;1- 2. http://www.ncbi.nlm.nih.gov/pubmed/32641195.

  20. Wiwanitkit V. Covid-19 and Kawasaki syndrome. Cardiol Young 2020; 30 (9): 1372. https://doi.org/10.1017/ S1047951120001894[Opens in a new window].

  21. Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Clinical features of patients with Kawasaki disease whose parents had the same disease. Arch Pediatr Adolesc Med 2004; 158 (12): 1166-9. doi. 10.1001/archpedi.158.12.1166.

  22. Dergun M, Kao A, Hauger SB, Newburger JW, et al. Familial occurrence of Kawasaki syndrome in North America. Arch Pediatr Adolesc Med 2005; 159 (9): 876-81. doi. 10.1001/ archpedi.159.9.876.

  23. Lu X, Zhang L, Du H, Li YY, et al. SARS-CoV-2 Infection in Children To. N Engl J Med 2020; 382 (17): 1663-5. doi. 10.1056/NEJMc2005073.

  24. Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med 2020; 383 (4): 347-58. doi. 10.1056/ NEJMoa2021756.

  25. Koné-Paut I, Cimaz R. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic. RMD open. 2020; 6 (2): 1-4. http:// creativecommons.org/licenses/by-nc/4.0/.

  26. Licciardi F, Pruccoli G, Denina M, Parodi E, et al. SARS-CoV- 2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children. Pediatrics 2020; 146 (2): e20201711. https://doi.org/10.1542/peds.2020- 1711.

  27. Pouletty M, Borocco C, Ouldali N, Caseris M, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): A multicentre cohort. Ann Rheum Dis. 2020; 79 (8): 999-1006. http://dx.doi.org/10.1136/annrheumdis- 2020-217960.

  28. Feldstein LR, Rose EB, Horwitz SM, Collins JP, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med 2020; 383 (4): 334-46. doi. 10.1056/NEJMoa2021680.

  29. Chiu JS, Lahoud-Rahme M, Schaffer D, Cohen A, et al. Kawasaki Disease Features and Myocarditis in a Patient with COVID-19. Pediatr Cardiol 2020; 1-3. https://doi. org/10.1007/s00246-020-02393-0.

  30. Theocharis P, Wong J, Pushparajah K, Mathur SK, et al. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. Eur Hear J Cardiovascular Imaging 2020;jeaa212. doi. 10.1093/ehjci/jeaa212.

  31. Regev T, Antebi M. Pediatric inflammatory multisystem syndrome with central nervous system involvement and hypocomplementemia following sars-cov-2 infection. Pediatr Infect Dis J 2020; 39 (8): 206-7. doi. 10.1097/ INF.0000000000002804.

  32. Harahsheh AS, Dahdah N, Newburger JW, Portman MA, et al. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic. J Pediatr 2020; 222: 261-2. https://doi.org/10.1016/j. jpeds.2020.04.052.

  33. Han CL, Zhao SL. Intravenous immunoglobulin gamma (IVIG) versus IVIG plus infliximab in young children with Kawasaki disease. Med Sci Monit. 2018; 24: 7264-70. doi. 10.12659/MSM.908678.

  34. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company’s public news and information. 2020.

  35. Grimaud M, Starck J, Levy M, Marais C, et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care 2020; 10 (1): 69. https://doi.org/10.1186/ s13613-020-00690-8.

  36. Blondiaux E, Parisot P, Redheuil A, Tzaroukian L, et al. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series Eléonore. Radiology 2020: 202288. https://doi. org/10.1148/radiol.2020202288.

  37. Ramcharan T, Nolan O, Lai CY, Prabhu N, et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatr Cardiol. 2020: 1-11. https:// doi.org/10.1007/s00246-020-02391-2.

  38. Toubiana J, Poirault C, Corsia A, Bajolle F, et al. Kawasakilike multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 2020; 369: m2094. https://doi. org/10.1136/bmj.m2094.

  39. Sokolovsky S, Soni P, Hoffman T, Kahn P, et al. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult. Am J Emerg Med. 2020;June 25: S0735-6757 (20): 30542-8. https://doi.org/10.1016/j.ajem.2020.06.053.

  40. Chérif MY, de Filette JMK, André S, Kamgang P, et al. Coronavirus disease 2019 -related Kawasaki-like disease in an adult: A case report. JAAD Case Reports 2020; 6 (8): 780- 782. https://doi.org/10.1016/j.jdcr.2020.06.023.

  41. Labé P, Ly A, Sin C, Nasser M, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatology Venereol 2020; 43 (10): e539-41. https://doi.org/10.1111/jdv.16666.

  42. Lidder AK, Pandit SA, Lazzaro DR. An adult with COVID-19 kawasaki-like syndrome and ocular manifestations. Am J Ophthalmol Case Reports 2020; 20: 100875. https://doi. org/10.1016/j.ajoc.2020.100875.

  43. Heidemann SM, Tilford B, Bauerfeld C, Martin A, et al. Three cases of pediatric multisystem inflammatory syndrome associated with COVID-19 due to SARS-CoV-2. Am J Case Rep 2020; 21: 1-5. 10.12659/AJCR.925779.

  44. Whittaker E, Bamford A, Kenny J, Kaforou M, et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. JAMA 2020; 324 (3): 259-69. doi.10.1001/ jama.2020.10369.

  45. Moraleda C, Serna-Pascual M, Soriano-Arandes A, Simó S, et al. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV- 2) in Spain. Clin Infect Dis 2020; ciaa1042: 1-5. https:// doi.org/10.1093/cid/ciaa1042.

  46. Cheung EW, Zachariah P, Gorelik M, Boneparth A, et al. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. JAMA - J Am Med Assoc 2020; 324 (3): 294-6. doi.10.1001/jama.2020.10374.

  47. Zhang M, Shi L, Li X, Lin Y, et al. Clinical Analysis of Kawasaki Disease Shock Syndrome Ming‑Ming. Chinese Med J 2017; 130 (6): 2891‑2.

  48. Ravelli A, Davì S, Minoia F, Martini A, et al. Macrophage Activation Syndrome. Hematol Oncol Clin North Am 2015; 29 (5): 927-41. https://doi.org/10.1016/j.hoc.2015.06.010.

  49. Yim D, Ramsay J, Kothari D, Burgner D. Coronary artery dilatation in toxic shock-like syndrome: The kawasaki disease shock syndrome. Pediatr Cardiol 2010; 31 (8): 1232-5. https://doi.org/10.1007/s00246-010-9771-0.

  50. World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19 2020. https:// www.who.int/publications-detail/multisystem-inflammatorysyndrome- in-children-and-adolescents-with-covid-19.

  51. CDC. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID- 19). Emergency Preparedness and Response. 2020.

  52. Ebina-Shibuya R, Namkoong H, Shibuya Y, Horita N. Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases. Int J Infect Dis 2020; 97: 371-3. https://doi. org/10.1016/j.ijid.2020.06.014.




2020     |     www.medigraphic.com